Prevalence of cardiovascular disease and ca… [Eur J Endocrinol. 2013] – PubMed – NCBI
CONCLUSION: Morbidity rate during cross-sex hormone therapy was relatively low, especially in trans men. We observed a higher prevalence of venous thrombosis, myocardial infarction, cerebrovascular disease and type 2 diabetes in trans women compared to control population. Trans men had similar morbidity rates compared to controls aside from increased type 2 diabetes prevalence..
This is a brand new long-term study of the effects of HRT on transgender persons that more or less confirms what the WPATHSoC already says. Still, it’s always nice to have confirming science for these things.
I gotta wonder though: why Type II Diabetes?